Xiaobo Zhang

Mrs. Xiaobo Zhang

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2022 in Cancer Research
Verified
Journal Article
Open access
PDF file
YWYicheng Wang
Yicheng Wang
HXHaoling Xie
Haoling Xie
XCXiaohong Chang
Xiaohong Chang
WHWenqi Hu
Wenqi Hu
MLMengyao Li
Mengyao Li
FTFuchou Tang
Fuchou Tang
High-grade serous cancer (HGSC) is the most common subtype of ovarian cancer. HGSC is highly aggressive with poor patient outcomes, and a deeper understanding of HGSC tumorigenesis could help guide future treatment development. To systematically characterize the underlying pathologic mechanisms and intratumoral heterogeneity in human HGSC, we used an optimized single-cell multiomics sequencing technology to simultaneously analyze somatic copy-number alterations (SCNA), DNA methylation, chromatin accessibility, and transcriptome in individual cancer cells. Genes associated with interferon signaling, metallothioneins, and metabolism were commonly upregulated in ovarian cancer cells. Integrated multiomics analyses revealed that upregulation of interferon signaling and metallothioneins was influenced by both demethylation of their promoters and hypomethylation of satellites and LINE1, and potential key transcription factors regulating glycolysis using chromatin accessibility data were uncovered. In addition, gene expression and DNA methylation displayed similar patterns in matched primary and abdominal metastatic tumor cells of the same genetic lineage, suggesting that metastatic cells potentially preexist in the subclones of primary tumors. Finally, the lineages of cancer cells with higher residual DNA methylation levels and upregulated expression of CCN1 and HSP90AA1 presented greater metastatic potential. This study characterizes the critical genetic, epigenetic, and transcriptomic features and their mutual regulatory relationships in ovarian cancer, providing valuable resources for identifying new molecular mechanisms and potential therapeutic targets for HGSC. Significance: Integrated analysis of multiomic changes and epigenetic regulation in high-grade serous ovarian cancer provides insights into the molecular characteristics of this disease, which could help improve diagnosis and treatment.

30 December 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
MLMingzhu Li
Mingzhu Li
CZChao Zhao
Chao Zhao
YZYun Zhao
Yun Zhao
JLJingran Li
Jingran Li
XZXiaobo Zhang
Xiaobo Zhang
Lihui WeiLihui Wei
Lihui Wei
Background: PAX1 methylation (PAX1m) and HPV viral load (VL) have been reported to detect cervical high-grade squamous intraepithelial lesions (HSIL), but the relationship between them is unclear. This study aimed to evaluate the correlation between HPV VL and PAX1m and its effectiveness in predicting cervical lesions. (2) Methods: A total of 476 women referred to colposcopy for abnormal cervical screening at the Peking University People’s Hospital between November 2020 and November 2021 were enrolled. PAX1m and HPV VL were determined by QMSP and BMRT-HPV reports type-specific VL/10,000 cells, respectively. (3) Results: PAX1m was significantly increased in HSIL, especially in cervical cancer, but there was no significant difference between cervical intraepithelial neoplasms 1(CIN1) and CIN2. However, HPV VL significantly differed between CIN1 and CIN2 but not between CIN3 and cervical cancer. In general, PAX1m positively correlated with all hrHPV VL, mainly in the HPV16/18 VL (p < 0.001), but had no relationship with the other 12 types of hrHPV VL. PAX1m had the highest specificity in diagnosing CIN2+, followed by HPV16/18 VL, which are higher than cytology ≥ASCUS. (4) Conclusions: Hypermethylation of PAX1 is associated with high HPV VL, especially HPV16/18, and both present advantageous specificity in detecting CIN2+.

30 May 2025 in Current Oncology
Verified
Journal Article
Open access
PDF file
YWYiqin Wang
Yiqin Wang
LBLinlin Bo
Linlin Bo
XFXiaowei Fan
Xiaowei Fan
NKNan Kang
Nan Kang
XZXiaobo Zhang
Xiaobo Zhang
JWJianliu Wang
Jianliu Wang
Objectives: The objective of this study was to investigate the significance of molecular classification in guiding treatment decisions for patients with endometrial cancer (EC) or atypical hyperplasia (AH) undergoing fertility-sparing treatment (FST), particularly for those with non-NSMP subtypes. Methods: We conducted a retrospective cohort study involving EC/AH patients undergoing FST and molecular classification using next-generation sequencing at Peking University People’s Hospital between June 2020 and September 2023. Results: A total of 118 EC/AH patients were included, including 92 cases with NSMP, 11 with MMRd, 11 with POLEmut, and 4 with p53abn. (1) Of the 11 patients with MMRd, 6 achieved a complete response (CR) with 1 case receiving progestin, 3 cases showed insensitivity to the initial progestin before transitioning to a combined regimen of progestin and a PD-1 inhibitor, and 2 cases initially received progestin plus a PD-1 inhibitor. There were no significant differences in the cumulative CR rates between the MMRd and NSMP subgroups but a trend of a lower relapse-free-survival (RFS) rate for the MMRd subgroup (p = 0.074). (2) Of the 11 cases with POLEmut, 10 achieved CR but 4 relapsed. There was also a trend for a lower RFS rate in the POLEmut patients (p = 0.069) compared with the NSMP subgroup. (3) Three of the four patients with p53mut achieved CR after treatment with the GnRHa plus LNG-IUS regimen. Conclusion: The selection of appropriate regimens may improve FST outcomes in EC/AH patients with molecular classification of non-NSMP subtypes. Immunotherapy is an effective fertility-preserving approach for patients with MMRd.

18 July 2025 in Pathology - Research and Practice
Verified
Journal Article
Closed access
BKBiqian KANG
Biqian KANG
BHBo Han
Bo Han
DSdanhua shen
danhua shen
GZGuo Zhang
Guo Zhang
XZXiaobo Zhang
Xiaobo Zhang

27 December 2024 in Gynecology and Obstetrics Clinical Medicine
Verified
Journal Article
Open access
PDF file
YZYixuan Zhen
Yixuan Zhen
XZXiaobo Zhang
Xiaobo Zhang
Endometrial carcinoma (EC) is one of the most common malignancies of the female reproductive system, with an increasing incidence and mortality rate. Endometrioid EC (EEC) was the most common type of EC. The microcystic, elongated and fragmented (MELF) pattern, a special mode of myometrial invasion newly discovered in recent years, mainly existed in low-grade EEC. Most EEC with MELF invasion had no specific molecular profile (NSMP EEC), and most NSMP EEC with MELF had a catenin beta 1 (CTNNB1) wild type. Apart from NSMP EEC, microsatellite instability-high was the most common molecular type. Initially considered a degenerative change, several researchers suggested an association between the MELF pattern and epithelial-mesenchymal transition. Several independent predictors of adverse outcomes, including tumour size, myometrial invasion, histological grade and lymphovascular space invasion, are related to the MELF pattern. This review aimed to remind pathologists of the clinicopathological features, molecular mechanisms and prognosis of the MELF pattern to avoid missed diagnosis or underdiagnosis.

21 October 2024 in Cancers
Verified
Journal Article
Open access
PDF file
XZXiaobo Zhang
Xiaobo Zhang
BHBo Han
Bo Han
DSdanhua shen
danhua shen
Background: Microcystic, elongated, and fragmented (MELF) invasion is a special invasion pattern in endometrioid endometrial cancer (EEC). This study aimed to investigate the clinical, pathological, and molecular features of the MELF pattern and its prognostic value in patients with EEC. Materials and Methods: The clinical and pathological data of 342 patients with EEC were retrospectively collected at Peking University People’s Hospital from January 2019 to December 2022. Some key clinicopathological features were evaluated, including the tumor grade, Federation of Gynecology and Obstetrics (FIGO) staging, cervical stromal involvement, lymph node status, and lymphatic vascular space infiltration (LVSI). Immunohistochemical staining and molecular tests were performed, and the relevant literature was reviewed. Results: The MELF pattern was more prevalent in low-grade EEC. A significant correlation was found between the MELF pattern and advanced FIGO staging, LVSI, the depth of myometrial invasion, cervical stromal involvement, and lymph node metastasis (LNM). The incidence of mismatch-repair-deficient (MMRd) proteins was much higher in the MELF group than in the no-MELF group. Molecular testing revealed that, after copy number—low (CNL), microsatellite instability—high (MSI-H) was the second-most frequent subtype in the MELF group. The recurrence risk did not significantly differ between the MELF and no-MELF groups, but the differences among the four molecular subtypes were statistically significant. However, the MELF group experienced a shorter recurrence time. Among the four molecular subtypes, the recurrence risk was the highest in the CNH subgroup, followed by the MSI-H subgroup. Conclusions: MELF is a special invasion pattern in EEC and is associated with distinct clinicopathological and molecular characteristics, including the latest 2023 FIGO staging. Further research is warranted to explore its implications for treatment strategies and patient outcomes.